Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
55,555,574
-
Shares change
-
+1,963,961
-
Total reported value, excl. options
-
$911,135,543
-
Value change
-
+$36,567,117
-
Put/Call ratio
-
73.94%
-
Number of buys
-
87
-
Number of sells
-
-67
-
Price
-
$16.4
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q4 2017
205 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q4 2017.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55,555,574 shares
of 294,683,714 outstanding shares and own 18.85% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6,871,509 shares), FMR LLC (5,355,421 shares), WASATCH ADVISORS INC (4,698,511 shares), Vanguard Group Inc (4,479,969 shares), STATE STREET CORP (3,979,593 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,400,000 shares), BAKER BROS. ADVISORS LP (2,113,376 shares), Casdin Capital, LLC (1,400,000 shares), Invesco Ltd. (1,376,028 shares), and D. E. Shaw & Co., Inc. (1,364,295 shares).
This table shows the top 167 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.